PD-Rx Pharmaceuticals, Inc. recalls Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC
PD-Rx Pharmaceuticals recalls 100mg Doxycycline Hyclate tablets with failed dissolution specifications. These tablets may not release medication properly, potentially affecting treatment effectiveness. Check NDC codes and expiration dates for affected batches.
Lower-risk recall
Failed dissolution specifications
Contact the company & request your remedy
What happened, in plain English
PD-Rx Pharmaceuticals is recalling 100mg Doxycycline Hyclate tablets that failed dissolution specifications. This means the tablets might not release medication properly, which could lead to ineffective treatment. Affected products include specific bottle sizes and expiration dates. Read more at govinfonow.com/recall/37118-pd-rx-doxycycline-tablets-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/37118-pd-rx-doxycycline-tablets-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-1276-2020
Cite this page
“PD-Rx Doxycycline Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37118-pd-rx-doxycycline-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-1276-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1276-2020%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release the medication properly. This could result in the medication not working as intended, leading to ineffective treatment for infections or skin conditions. The risk is primarily about treatment effectiveness rather than immediate harm.
Who’s affected
People who have the recalled Doxycycline Hyclate tablets (100mg) from PD-Rx Pharmaceuticals, including those with prescription orders for infections or skin conditions. Those taking the medication for chronic conditions like acne or Lyme disease are most at risk if the tablets don't dissolve correctly.
How to tell if you have this one
Check for bottles labeled 'Doxycycline Hyclate tablets USP, 100 mg' with NDC codes 55289-866-06 through 55289-866-87. The expiration dates range from June 30, 2020, to December 31, 2021, depending on the batch.
- Brand
PD-Rx- Category
Drug
What to do — step by step
Check Product Details
Identify the NDC code and expiration date on your bottle to confirm if it's affected.
Contact Your Doctor
Discuss alternative treatment options with your healthcare provider if you have the recalled tablets.
Questions people ask
Why is this recall happening?
The tablets failed dissolution specifications, meaning they may not release medication properly, which could lead to ineffective treatment.
What should I do if I have the recalled tablets?
Check the NDC code and expiration date on your bottle. If affected, contact your doctor for alternative treatment options.
Are there any immediate health risks from using these tablets?
No immediate health risks are reported; the recall is due to potential treatment ineffectiveness, not physical harm.
Contact PD-Rx
We’ve drafted a message you can send PD-Rx to request your refund or repair — edit it as you like.
Subject: Recall D-1276-2020 — PD-Rx PD-Rx Hello, I own a PD-Rx that is covered by recall D-1276-2020 from PD-Rx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1276-2020 (May 15, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1276-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.